Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Carcinoma In Situ × exemestane × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 59 Neoplasm Metastasis 3 Breast Neoplasms, Male 3 Neoplasms 2 Sleep Wake Disorders 1 Ovarian Neoplasms 1 First Line Metastatic Breast Cancer 1 Fatigue 1 Carcinoma, Intraductal, Noninfiltrating 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Advanced Breast Cancer 1

Interventions

Tamoxifen 4 Radiotherapy 2 Medroxyprogesterone 2 Letrozole 2 Chemotherapy, Adjuvant 2 pembrolizumab 1 oxybutynin 1 exemestane 1 Watchful Waiting 1 Specimen Handling 1 Risedronic Acid 1 Radiation 1 Observation 1 Norethindrone Acetate 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Fentanyl 1 Estrogens, Conjugated (USP) 1 Estradiol 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671912 2026-03-04

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡